ºÐ°ú | ½Ã°£ | ±³À°ÁÖÁ¦ | ¼Ò¼Ó | °»ç¸í |
¼Òȱâ |
¼Òȱâ ÁúȯÀÇ ÃֽŠÁö°ß | <ÁÂÀå: À̵¿ÈĤýÀ¯Á¾¼±> |
|
08:30~09:00 |
±â´É¼º À§Àå Áúȯ°ú ³»Àå°ú¹Î¼º |
ÇѾçÀÇ´ë |
ÀÌ¿À¿µ |
09:00~09:30 |
Ç︮ÄÚ¹ÚÅÍ¿¡ ÀÇÇÑ ¼ÒȺҷ®ÁõÀÇ Áø´Ü°ú Ä¡·á |
°¡Å縯ÀÇ´ë |
¹Ú¼öÇå |
09:30~10:00 |
°Å´ë ¿ëÁ¾ ¹× Á¶±â ´ëÀå¾ÏÀÇ Ä¡·á: ³»½Ã°æÀû vs ¼ö¼úÀû Ä¡·á |
¼øõÇâÀÇ´ë |
±èÁø¿À |
10:00~10:30 |
Coffee break |
10:30~11:00 |
Ãé´ãµµÁúȯÀÇ Ä¡·á³»½Ã°æ |
¾ÆÁÖÀÇ´ë |
±èÁøÈ« |
11:00~11:30 |
¾àÀμº °£¼Õ»ó(Drug-Induced Liver Injury) |
ÇѸ²ÀÇ´ë |
±èµ¿ÁØ |
È£Èí±â |
°á ÇÙ | <ÁÂÀå: ¹Ú°æ¿Á¤ýÁ¤ÅÂÈÆ> |
|
08:30~08:55 |
¿ªÇÐ ¹× º´Å»ý¸® |
Àü³²ÀÇ´ë |
±èÀ¯ÀÏ |
08:55~09:20 |
ÃÖ½ÅÁø´Ü |
¿ï»êÀÇ´ë |
½Éż± |
09:20~09:45 |
Ç×°áÇÙÁ¦ÀÇ ºÎÀÛ¿ë°ú ´ëÄ¡ |
°¡Å縯ÀÇ´ë |
¹®È½Ä |
09:45~10:15 |
Coffee break |
10:15~10:40 |
Ư¼ö »óȲ¿¡¼ÀÇ °áÇÙÀÇ Ä¡·á |
ÇѾçÀÇ´ë |
±èÅÂÇü |
10:40~11:05 |
¿øÁÖÀÇ´ë |
¿øÁÖÀÇ´ë |
¿ë¼®Áß |
11:05~11:30 |
ºñ°áÇÙÇ×»ó±ÕÁúȯÀÇ Ä¡·á |
¼º±Õ°üÀÇ´ë |
°í¿øÁß |
½Å Àå |
Nephrology Uptodate: Board Review | |
|
Acid-Base and Electrolyte |
|
08:30~09:00 |
Electrolyte clinical Overview |
Àü³²ÀÇ´ë |
±è¼ö¿Ï |
|
09:00~09:30 |
Treatment of Glomerulonephritis |
¼º±Õ°üÀÇ´ë |
±èÀ±±¸ |
|
09:30~10:00 |
Cardiovascular Disease in ESRD patients |
¿¬¼¼ÀÇ´ë |
±è¹ü¼® |
10:00~10:20 |
Coffee break |
10:20~10:50 |
Complications & Management in PD |
°æºÏÀÇ´ë |
±è¿ë¸² |
10:50~11:20 |
Complications & Management in HD |
ÀÎÇÏÀÇ´ë |
À̽¿ì |
11:20~11:30 |
Discussions |